Jianguang Hu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Jianguang Hu has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- Danping Qin
Department of Nephrology, Guangzhou Red Cross Hospital, Medical College, Jinan University, Guangzhou, China
2 shared publications - Daoyuan Zhou
Department of Nephrology, Guangzhou Red Cross Hospital, Medical College, Jinan University, Guangzhou, China
2 shared publications - Jing Yan
Department of Nephrology, Guangzhou Red Cross Hospital, Medical College, Jinan University, Guangzhou, China
2 shared publications - Xiao Xiao
Department of Nephrology, Guangzhou Red Cross Hospital, Medical College, Jinan University, Guangzhou, China
2 shared publications - Yuanyuan Zheng
Department of Nephrology, Guangzhou Red Cross Hospital, Medical College, Jinan University, Guangzhou, China
2 shared publications - Luona Wen
Department of Nephrology, Guangzhou Red Cross Hospital, Medical College, Jinan University, Guangzhou, China
1 shared publication
Latest Publications
- Open Access
- 4 April 2022
- Published by Springer Nature in BMC Nephrology
- Vol. 23 (1) , 1-12
Correlation between intestinal flora disruption and protein–energy wasting in patients with end-stage renal disease
Background: Different dialysis treatments may affect the composition and structure of the intestinal flora of dialysis-treated chronic kidney disease (CKD) patients. This study aimed to analyze the correlations between the different flora and the nutritional indexes and further explore the potential metabolic pathways in patients with CKD in end-stage renal disease (ESRD).Methods: Altogether, 102 patients with ESRD were recruited and categorized into the hemodialysis (HD) group (N = 49) and the peritoneal dialysis (PD) group (N = 53). Their biochemical indexes, anthropometric indicators, and inflammatory markers were determined. The total genomic DNA was extracted for 16S ribosomal DNA sequencing. Furthermore, bioinformatics analysis was employed for functional analysis.Results: Anthropometric indicators, including handgrip strength, mid-upper arm circumference, mid-upper arm muscle circumference, and body mass index, in the HD and PD groups showed a positive correlation with butyric acid-producing bacteria (RosellaandPhascolarctobacterium) and a negative correlation with conditional pathogens (Escherichiaspp.). Meanwhile, the inflammatory markers, including high-sensitivity C-reactive protein and interleukin-6, were significantly higher in the PD-protein–energy wasting (PEW) group than in the PD-non-protein–energy wasting (NPEW) group; although they showed an increasing trend in the HD-PEW group, no significant difference was noted.Rosellawas considerably scarce in the HD-PEW group than in the HD-NPEW group, whereasEscherichiawas substantially more abundant in the PD-PEW group than in the PD-NPEW group. Compared with the HD group, the essential amino acid synthesis pathway, amino acid metabolism-related enzyme pathways, and aminoacyl-transfer RNA biosynthesis pathways were weakened in the PD group. Most carbohydrate metabolic pathways were weakened, although the tricarboxylic acid cycle was slightly enhanced. Concurrently, the fatty acid metabolism was enhanced, whereas fatty acid synthesis was weakened; the metabolic pathways of B vitamins were also weakened. These potential metabolic pathways of the various compounds released by intestinal flora showed a significant correlation with blood biochemical indexes, anthropometric indicators, and inflammatory markers.Conclusion: In patients with ESRD, different dialysis treatments affected the abundance of butyric acid-producing bacteria (RosellaandPhascolarctobacterium) and conditional pathogens (Escherichiaspp.). Butyric acid-producing bacteria showed a positive correlation with PEW and showed a negative correlation withEscherichia. Improving the intestinal diversity and increasing the amount of butyric acid-producing bacteria, such asBlautella, Faecococcus, andPhascolarctobacterium, are potential therapeutic approaches to enhance protein–energy consumption in patients with ESRD.
- 4 April 2022
- Published by Springer Nature in BMC Nephrology
- Vol. 23 (1) , 1-12
Open AccessCorrelation between intestinal flora disruption and protein–energy wasting in patients with end-stage renal disease
Background: Different dialysis treatments may affect the composition and structure of the intestinal flora of dialysis-treated chronic kidney disease (CKD) patients. This study aimed to analyze the correlations between the different flora and the nutritional indexes and further explore the potential metabolic pathways in patients with CKD in end-stage renal disease (ESRD).Methods: Altogether, 102 patients with ESRD were recruited and categorized into the hemodialysis (HD) group (N = 49) and the peritoneal dialysis (PD) group (N = 53). Their biochemical indexes, anthropometric indicators, and inflammatory markers were determined. The total genomic DNA was extracted for 16S ribosomal DNA sequencing. Furthermore, bioinformatics analysis was employed for functional analysis.Results: Anthropometric indicators, including handgrip strength, mid-upper arm circumference, mid-upper arm muscle circumference, and body mass index, in the HD and PD groups showed a positive correlation with butyric acid-producing bacteria (RosellaandPhascolarctobacterium) and a negative correlation with conditional pathogens (Escherichiaspp.). Meanwhile, the inflammatory markers, including high-sensitivity C-reactive protein and interleukin-6, were significantly higher in the PD-protein–energy wasting (PEW) group than in the PD-non-protein–energy wasting (NPEW) group; although they showed an increasing trend in the HD-PEW group, no significant difference was noted.Rosellawas considerably scarce in the HD-PEW group than in the HD-NPEW group, whereasEscherichiawas substantially more abundant in the PD-PEW group than in the PD-NPEW group. Compared with the HD group, the essential amino acid synthesis pathway, amino acid metabolism-related enzyme pathways, and aminoacyl-transfer RNA biosynthesis pathways were weakened in the PD group. Most carbohydrate metabolic pathways were weakened, although the tricarboxylic acid cycle was slightly enhanced. Concurrently, the fatty acid metabolism was enhanced, whereas fatty acid synthesis was weakened; the metabolic pathways of B vitamins were also weakened. These potential metabolic pathways of the various compounds released by intestinal flora showed a significant correlation with blood biochemical indexes, anthropometric indicators, and inflammatory markers.Conclusion: In patients with ESRD, different dialysis treatments affected the abundance of butyric acid-producing bacteria (RosellaandPhascolarctobacterium) and conditional pathogens (Escherichiaspp.). Butyric acid-producing bacteria showed a positive correlation with PEW and showed a negative correlation withEscherichia. Improving the intestinal diversity and increasing the amount of butyric acid-producing bacteria, such asBlautella, Faecococcus, andPhascolarctobacterium, are potential therapeutic approaches to enhance protein–energy consumption in patients with ESRD.
- Open Access
- 13 January 2020
- Published by Springer Nature in BMC Nephrology
- Vol. 21 (1) , 1-11
High-throughput sequencing analysis of intestinal flora changes in ESRD and CKD patients
Background: Chronic kidney disease (CKD) disease affects gut flora by causing dysbiosis and lead to systemic inflammatory conditions. Here, we provide intestinal flora changes of CKD patients undertook different hemodialysis therapy. Methods: From 2017 to 2019, a total of 166 patients from Guangzhou Red Cross Hospital were recruited and divided into four groups with 17 cases in healthy control group, 47 cases in CKD non-dialysis group, 49 cases in HD group, and 53 cases in PD group. Intestinal flora genome 16S rDNA sequencing and further bio-informatic analysis were performed. Results: Decreased diversity and altered communities of intestinal flora in PD patients, in which microbial diversity was positive correlated with the albumin level were observed. A total of 20 intestinal flora phyla were detected in 166 fecal samples, divided into 3 dominant intestinal types including Bacteroides-dominant gut type, Firmicutes-dominant type and Proteobacteria-dominant gut type. Further analyses found 198 genera, the abundance of 86 genera were significantly different. Butyrate-producing taxa as Faecalibacterium in genera level and Bifidobacteriaceae and Prevotellaceae in family level were dominant genus in CT, CKD, and HD groups, while urease containing-, indole- and p-cresol-forming taxa as Escherichia in genera and Enterobacteriaceae, Enterococcaceae in family level was dominated genus in PD group. Number of differential expressed genes in KEGG enrichment pathways were significantly different in PD group in carbohydrate metabolism, amino acid metabolism, energy metabolism, translation, and membrane transport. Conclusion: Our results suggest peritoneal dialysis therapy could result in reduced diversity and altered microbial communities, with reduced probiotic butyrate-producing taxa and increased urease containing-, indole- and p-cresol-forming taxa. The disordered intestinal flora can seriously affect the nutrition level in CKD patients with PD therapy.
- 13 January 2020
- Published by Springer Nature in BMC Nephrology
- Vol. 21 (1) , 1-11
Open AccessHigh-throughput sequencing analysis of intestinal flora changes in ESRD and CKD patients
Background: Chronic kidney disease (CKD) disease affects gut flora by causing dysbiosis and lead to systemic inflammatory conditions. Here, we provide intestinal flora changes of CKD patients undertook different hemodialysis therapy. Methods: From 2017 to 2019, a total of 166 patients from Guangzhou Red Cross Hospital were recruited and divided into four groups with 17 cases in healthy control group, 47 cases in CKD non-dialysis group, 49 cases in HD group, and 53 cases in PD group. Intestinal flora genome 16S rDNA sequencing and further bio-informatic analysis were performed. Results: Decreased diversity and altered communities of intestinal flora in PD patients, in which microbial diversity was positive correlated with the albumin level were observed. A total of 20 intestinal flora phyla were detected in 166 fecal samples, divided into 3 dominant intestinal types including Bacteroides-dominant gut type, Firmicutes-dominant type and Proteobacteria-dominant gut type. Further analyses found 198 genera, the abundance of 86 genera were significantly different. Butyrate-producing taxa as Faecalibacterium in genera level and Bifidobacteriaceae and Prevotellaceae in family level were dominant genus in CT, CKD, and HD groups, while urease containing-, indole- and p-cresol-forming taxa as Escherichia in genera and Enterobacteriaceae, Enterococcaceae in family level was dominated genus in PD group. Number of differential expressed genes in KEGG enrichment pathways were significantly different in PD group in carbohydrate metabolism, amino acid metabolism, energy metabolism, translation, and membrane transport. Conclusion: Our results suggest peritoneal dialysis therapy could result in reduced diversity and altered microbial communities, with reduced probiotic butyrate-producing taxa and increased urease containing-, indole- and p-cresol-forming taxa. The disordered intestinal flora can seriously affect the nutrition level in CKD patients with PD therapy.